Tetra Bio-Pharma Inc.
TBPMQ
OTC PK
| 08/31/2022 | 05/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.64% | 9.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.63% | 115.20% | |||
| Operating Income | -4.63% | -115.20% | |||
| Income Before Tax | 7.40% | -128.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.40% | -128.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.40% | -128.63% | |||
| EBIT | -4.63% | -115.20% | |||
| EBITDA | -4.68% | -117.00% | |||
| EPS Basic | 8.57% | -125.81% | |||
| Normalized Basic EPS | 0.00% | -90.00% | |||
| EPS Diluted | 8.57% | -125.81% | |||
| Normalized Diluted EPS | 0.00% | -90.00% | |||
| Average Basic Shares Outstanding | 1.68% | 1.14% | |||
| Average Diluted Shares Outstanding | 1.68% | 1.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||